Seborrhea is a common skin condition in dogs characterized by abnormal keratinization, the process by which skin cells mature and are shed. This disorder results in either excessively dry, flaky skin called seborrhea sicca, or excessively oily, greasy skin called seborrhea oleosa, or a combination of both presentations. The condition affects the skin's normal turnover process, causing skin cells to reproduce and shed more rapidly than normal, leading to visible scaling, flaking, and changes in coat quality that can significantly affect a dog's comfort and appearance.
The underlying mechanism of seborrhea involves dysfunction in the normal skin cell cycle. In healthy skin, cells produced in the basal layer migrate to the surface over approximately three weeks, dying and being shed as they reach the outermost layer. In seborrheic dogs, this process is accelerated, often completing in just a few days. Additionally, sebaceous gland function may be altered, producing either too much or abnormally composed sebum. The combination of rapid cell turnover and altered sebum production creates the characteristic clinical signs.
Seborrhea significantly impacts affected dogs through chronic skin irritation, secondary infections, and compromised quality of life. Dogs with seborrhea often experience persistent itching that leads to scratching and skin damage. The abnormal skin environment promotes secondary bacterial and yeast infections that worsen symptoms. The characteristic odor associated with seborrhea can affect the human-animal bond and limit social interactions. Coat quality deterioration affects the dog's appearance and may reduce insulating properties of the fur.
While seborrhea cannot typically be cured, particularly in its primary inherited form, it can usually be well managed with appropriate ongoing treatment. Understanding whether seborrhea is primary or secondary to another condition is essential for effective management. Secondary seborrhea caused by underlying diseases may resolve when the primary condition is treated. Management focuses on normalizing the skin's condition through topical therapies, controlling secondary infections, and addressing any underlying causes contributing to the condition.
